News
News
- Details
The novel coronavirus has been compared with the flu almost from the moment it emerged in late 2019. They share a variety of symptoms, and in many cases, an influenza test is part of the process for diagnosing COVID-19. Researchers at The University of Texas at Austin are now developing a new sensor that can tell the difference between the two illnesses and test for both simultaneously.
- Details
The country’s first peer-reviewed study of a COVID-19 treatment that transfuses blood plasma from recovered patients into critically ill patients shows 19 out of 25 patients improving, including 11 discharged from the hospital. On March 28, Houston Methodist Hospital became the first academic medical center in the U.S. to transfuse plasma from recovered COVID-19 patients into two critically ill patients. Collaborators at The University of Texas at Austin, including Jason Lavinder, research associate in the McKetta Department of Chemical Engineering in the Cockrell School of Engineering, developed an antibody test and selected recovered patients with the highest levels of antibody response for donation.